You are here

In global race for cancer therapy, a Chinese biotech firm surges


IN THE global race to use human immune cells to fight cancers, a little-known Chinese firm called GenScript Biotech Corp is emerging as one of the biggest stock gainers.

Among the first Chinese developers of so-called CAR-T cancer therapies, GenScript's shares have risen

Market voices on:

Powered by GET.comGetCom